The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma - Summary - MDSpire

The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma

  • By

  • Maria Gavriatopoulou

  • Andriani Βoultadaki

  • Vassilis Koutoulidis

  • Ioannis Ntanasis-Stathopoulos

  • Charis Bourgioti

  • Panagiotis Malandrakis

  • Despina Fotiou

  • Magdalini Migkou

  • Nikolaos Kanellias

  • Evangelos Eleutherakis-Papaiakovou

  • Efstathios Kastritis

  • Evangelos Terpos

  • Meletios A. Dimopoulos

  • Lia-Angela Moulopoulos

  • September 25, 2020

  • 0 min

Share

Objective:

To evaluate the role of low dose whole body CT (WBLDCT) in the early identification of patients with asymptomatic multiple myeloma (MM) who progress with bone disease only, highlighting its significance in treatment outcomes.

Key Findings:
  • WBLDCT is sensitive in detecting small osteolytic lesions <5 mm, which is crucial for timely intervention.
  • Technological advances allow for low radiation exposure comparable to conventional radiography, enhancing patient safety.
  • WBLDCT has been incorporated into the latest IMWG diagnostic criteria, underscoring its clinical relevance.
Interpretation:

WBLDCT is a valuable tool for early detection of progression in patients with SMM, enabling timely treatment initiation.

Limitations:
  • Study limited to patients with SMM and may not generalize to all MM patients, necessitating further research.
  • Potential biases in image interpretation despite blinding, which could affect results.
Conclusion:

WBLDCT effectively identifies asymptomatic MM patients at risk of progression, supporting its role in clinical management and emphasizing the need for its integration into routine practice.

Original Source(s)

The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma

  • by Maria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, Charis Bourgioti, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Lia-Angela Moulopoulos

  • September 25, 2020

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms

Computed tomography-derived sarcopenia, enteral nutritional support, and febrile neutropenia burden in children with acute lymphoblastic leukemia: a retrospective cohort study